Surendralal Karsanbhai Elected to Merck Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- US stock futures rise on tech rebound before Nvidia, inflation tests
- Oil hits one-week low as investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- Six Flags to move headquarters from Charlotte to Arlington, Texas
BMO Capital Reiterates Outperform Rating on Merck (MRK)
November 25, 2024 8:01 AM ESTBMO Capital analyst Evan David Seigerman reiterated an Outperform rating and $136.00 price target on Merck (NYSE: MRK).
The analyst comments "ZENITH trial has been stopped early due to overwhelming efficacy of sotatercept in functional class III/IV PAH patients. Following the compelling... More
